F. Hoffmann-La Roche Ltd. v. Empagran S. A.

Background

A group of vitamin manufacturers and distributors agreed to fix prices worldwide, raising vitamin prices in the United States and in other countries. Foreign distributors in Ukraine, Australia, Ecuador, and Panama sued in the United States for their overseas losses, even though their purchases were made and delivered entirely outside U.S. commerce. Lower courts split on whether U.S. antitrust law could reach those foreign-only injuries, and the Supreme Court agreed to decide the matter.

Reasoning

The Court asked whether the Foreign Trade Antitrust Improvements Act (FTAIA) lets U.S. antitrust law apply when conduct is largely foreign but also produces some domestic effects and separate foreign harm. The Court said the FTAIA’s general rule excludes conduct “involving trade or commerce … with foreign nations” from the Sherman Act, and that the statute’s exception does not permit private suits based solely on independent foreign injury. The majority emphasized respect for other countries’ authority (comity), the statute’s text and history, and concerns about imposing U.S. treble-damages remedies on conduct that primarily affects foreign markets. The Court therefore held foreign purchasers cannot recover under the Sherman Act for harms that are purely foreign, while U.S. purchasers may sue for domestic injury.

Real world impact

The decision limits foreign plaintiffs’ ability to use U.S. courts to get damages for overseas price increases and reduces the risk that American remedies will override foreign enforcement choices. The Court vacated the appeals court judgment and sent the case back to consider any argument that the foreign harm was actually caused by domestic effects; that question was left for the lower court to resolve.